Efficacy and safety of upadacitinib in treating immune drift: a single-center, prospective study in China
IntroductionWith the widespread use of biologic agents in dermatology, immune drift has emerged as a growing clinical challenge. Although several case reports suggest the therapeutic potential of JAK inhibitors, clinical evidence for upadacitinib—a hig…